Trevi Therapeutics (TRVI) Q1 2023 Earnings

11MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.18
-0.14
-0.1
-0.06

Details

Expected EPS
-0.07
Actual EPS
-0.06
Surprise EPS
0.01
Surprise Percent
+14.29%

Description

Trevi Therapeutics (TRVI) has reported earnings of -0.06 per share for Q1 2023.

0 Comments

Share your thoughts